Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

NCT02750007 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: HS-20004

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.